GENOTOXICITY OF ETHIDIUM BROMIDE IN ALBINO MICE TREATED WITH BACTERIAL PROBIOTIC
Abstract
Ethidium bromide (EtBr) is a nucleic acid intercalating agent used extensively as a fluorescent dye in molecular genetics laboratories. The current study aimed to determine the potential histo- and genotoxicity of EtBr and investigate the antigenotoxic effect of probiotic bacteria (Lactic Acid bacteria; LAB) on mammalian tissue (albino mice). Mice were randomly divided into seven groups, with seven different treatments. Different EtBr doses were used individually as drinking solutions with and without probiotic bacteria, which was introduced as a single dose as a food additive. After one month of the treatments, the liver was tested using histological assay, DNA fragmentation analysis, and quantitative RT-PCR technique. No significant genotoxic effect for EtBr on the liver was observed on histo- logical examination and DNA fragmentation analysis. However, a considerable increase in the expression of the p53 gene and correlated with the dosages increase. However, the p53 expression was altered upon applying the probiotics, while some histological changes were detected, but no DNA fragmentation was detected. The seriousness of EtBr on the organism's health is conditional with the applied doses. Probiotics were not luckier than EtBr; it did not provide expected health benefits. This unexpected action of probiotics may be due to the used dose and how to use it. Further analysis of both histological and molecular aspects using multiple controls and integrative experiments is required to explain probiotics' paradox effect versus
the EtBr effect on mammalian cells and tissues.
Keywords: EtBr, Probiotic bacteria, genotoxicity, q-PCR, DNA fragmentation.
References
Adams L. A., Lymp J. F., Sauver J. S., Sanderson S. O., Lindor K. D., Feldstein, A. and Angulo P., (2005). The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastro-enterology, 129: 113-121.
Bartlett K., and Eaton S., (2004). Mitochondrial β-oxidation. European Journal of Biochemistry, 271: 462-469.
Bigorgne A., Bouchet–Delbos L., Naveau S., Dagher I., Prévot S., Durand-Gasselin I. and Perlemuter G., (2008). Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice. Gastroenterology, 134: 1459-1469.
Burns A. and Rowland I., (2000). Anti-carcinogenicity of probiotics and prebiotics. Current Issues in Intestinal Microbiology, 1: 13-24.
Burns A. J. and Rowland I. R., (2004). Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 551: 233-243.
Cahill P. A., Knight A. W., Billinton N., Barker M. G., Walsh L., Keenan P. O. and Walmsley R. M., (2004). The GreenScreen® genotoxicity assay: a screening validation programme. Mutagenesis, 19: 105-119.
Capurso G., Marignani M. and Delle Fave, G., (2006). Probiotics and the incidence of colorectal cancer: when evidence is not evident. Digestive and Liver Disease, 38: S277-S282.
Corsetti A., Caldini G., Mastrangelo M., Trotta F., Valmorri, S. and Cenci G., (2008). Raw milk traditional Italian ewe cheeses as a source of Lactobacillus casei strains with acid-bile resistance and antigenotoxic properties. International Journal of Food Microbiology, 125: 330-335.
Dancygier H. and Schirmacher P., (2010). Liver Cell Degeneration and Cell Death. 9Clinical Hepatology. Springer Berlin Heidelberg, 207-218.
de Franchis R., (2010). Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology, 53: 762-768.
Desilet N., Campbell T. N. and Choy F. Y., (2010). p53-based anti-cancer therapies: an empty promise? Current Issues in Molecular Biology, 12: 143.
Dominici L., Moretti M., Villarini M., Vannini S., Cenci G., Zampino C. and Traina G., (2011). In vivo antigenotoxic properties of a commercial probiotic supplement containing bifidobacteria. International Journal of Probiotics & Prebiotics, 6(3/4): 179.
Fabbrini E. and Magkos F., (2015). Hepatic steatosis as a marker of metabolic dysfunction. Nutrients, 7: 4995-5019.
Garbett N., Ragazzon P. and Chaires J., (2007). Circular dichroism to determine binding mode and affinity of ligand–DNA interactions. Nature Protocols, 2: 3166-3172.
Hall S., (1996). Chemical exposure and toxic responses. CRC Press.
Harisha S., (2005). An introduction to practical biotechnology. Firewall Media.
Hill C., Guarner F., Reid G., Gibson G. R., Merenstein D. J., Pot B. and Calder P. C., (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the term probiotic's scope and appropriate use. Nat Rev Gastroenterol Hepatol, 11: 506-514.
Isobe M., Emanuel B. S., Givol D., Oren M., and Croce C. M., (1986). Localization of gene for human p53 tumour antigen to band 17p13. Nature, 320(6057), 84-85.
James K. M., MacDonald K. W., Chanyi R. M., Cadieux P. A. and Burton J. P. (2016). Inhibition of Candida albicans biofilm formation and modulation of gene expression by probiotic cells and supernatant. Journal of Medical Microbiology, 65: 328-336.
Kakar S., Kamath P. and Burgart L. J., (2004). Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment? Archives of Pathology & Laboratory Medicine, 128: 901-904.
Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U. and Decordier I., (2003). Indirect mechanisms of genotoxicity. Toxicology Letters, 140: 63-74.
Klaassen C., (2013). Casarett and Doull's toxicology: the basic science of poisons (Vol. 1236). New York (NY): McGraw-Hill.
Li W., and Li C. B., (2003). Lack of inhibitory effects of lactic acid bacteria on 1, 2-dimethylhydrazine-induced colon tumors in rats. World Journal of Gastroenterology, 9: 2469.
Lisman T., Caldwell S., Burroughs A., Northup P., Senzolo M., Stravitz R. and Coagulation in Liver Disease Study Group, (2010). Hemostasis and thrombosis in patients with liver disease: the ups and downs. Journal of Hepatology, 53: 362-371.
Lisman T., Leebeek F. and de Groot P., (2002). Haemostatic abnormalities in patients with liver disease. Journal of Hepatology, 37: 280-287.
Lukjancenko O., Ussery D. W. and Was-senaar T. M., (2012). Comparative genomics of Bifidobacterium, Lactobacillus and related probiotic genera. Microbial Ecology, 63: 651-673.
Mackay A. D., Taylor M. B., Kibbler C. C. and Hamilton-Miller J. M., (1999). Lactobacillus endocarditis caused by a probiotic organism. Clinical Microbiology and Infection, 5: 290-292.
Madrigal-Santillán E., Madrigal-Bujaidar E., Márquez-Márquez R. and Reyes A., (2006). Antigenotoxic effect of Saccharomyces cerevisiae on the damage produced in mice fed with aflatoxin B 1 contaminated corn. Food and Chemical Toxicology, 44: 2058-2063.
McGill M., Pathak S. and Hsu T. C., (1974). Effects of ethidium bromide on mitosis and chromosomes: a possible material basis for chromosome stickiness. Chromosoma, 47: 157-166.
Mehta K., Van Thiel D., Shah N. and Mobarhan S., (2002). Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutrition reviews, 60: 289-293.
MohaniaD., Kansal V., Sagwal R. and Shah D., (2013). Anticarcinogenic effect of probiotic Dahi and piroxicam on DMH-induced colorectal carcinogenesis in Wistar rats. American Journal of Cancer Therapy and Pharmacology, 1: 8-24.
Na M., Koo S., Kim D., Dai Park S., Kang K. and Joe C., (1995). In vitro inhibition of gap junctional intercellular communication by chemical carcinogens. Toxicology, 98: 199-206.
Nagpal R., Kumar A., Kumar M., Behare P. V., Jain S. and Yadav H., (2012). Probiotics, their health benefits, and applications for developing healthier foods: a review. FEMS Microbiology letters, 334: 1-15.
Navarro V. J. and Senior J. R., (2006). Drug-related hepatotoxicity. New England Journal of Medicine, 354: 731-739.
Nelson W. G. and Kastan M. B., (1994). DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Molecular and Cellular Biology, 14: 1815-1823.
Northup P., Sundaram V., Fallon M., Reddy K., Balogun R., Sanyal A. and Caldwell S., (2008). Hypercoagulation and thrombophilia in liver disease. Journal of Thrombosis and Haemostasis, 6: 2-9.
Ohno K., Tanaka-Azuma Y., Yoneda Y. and Yamada T., (2005). Genotoxicity test system based on p53R2 gene expression in human cells: examination with 80 chemicals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 588: 47-57.
Oren M., Damalas A., Gottlieb T., Michael D., Taplick J., Leal J. F. and Ben-Ze'ev A. V., (2002). Regulation of p53. Annals of the New York Academy of Sciences, 973: 374-383.
Patten D. and Laws A., (2015). Lactobacillus-produced exopolysaccharides and their potential health benefits: a review. Beneficial Microbes, 6: 457-471.
Pool-Zobel B. L., Neudecker C., Domizlaff I., Ji S., Schillinger U., Rumney C. and Rowland I., (1996). Lactobacillus-and Bifidobacterium-mediated antigen-otoxicity in the colon of rats, Nutrition and Cancer, 26: 365-380.
Prabhu N., Sudha E., Anna J. and Soumya T., (2010). Effect of Rosa multiflora extracton chemical mutagens using Ames Assay. Der Pharma Chemica, 2: 91-97.
Sakai A., Sasaki K., Muramatsu D., Arai S., Endou N., Kuroda S. and Tanaka N., (2010). A Bhas 42 cell transformation assay on 98 chemicals: the characteristics and performance for the prediction of chemical carcinogenicity. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 702:100-122.
Shalke S., (2013). The application of probiotics in decrease cancer. Journal of Biomedical and Pharmaceutical Research, 2(3).
Singer V. L., Lawlor T. E. and Yu S., (1999). Comparison of SYBR® Green I nucleic acid gel stain mutagenicity and ethidium bromide mutagenicity in the Salmonella/mammalian microsome reverse mutation assay (Ames test). Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 439: 37-47.
Slashinski, M. J., McCurdy S. A., Achenbaum L. S., Whitney S. N. and McGuire A. L., (2012). "Snake-oil" "quack medicine," and "industrially cultured organisms:" biovalue and the commercialization of human microbiome research. BMC Medical Ethics, 13: 28.
Snyder R. D. and Arnone M. R., (2002). Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutation Rsearch/ Fundamental and Molecular Mechanisms of Mutagenesis, 503: 21-35.
Tiniakos D., Vos M. and Brunt E., (2010). Nonalcoholic fatty liver disease: pathology and pathogenesis. Annual Review of Pathological Mechanical Disease, 5: 145-171.
Treinen-Moslen M., (2001). Toxic responses of the liver, In: Klassen, C.D. (Ed.), Casarett & Doull's Toxicology: The Basic Science of Poisons, 6th ed. McGraw-Hill, International Edition, p: 471-489.
Van den Nieuwboer M., Brummer R. J., Guarner F., Morelli L., Cabana M. and Claassen E., (2015). Safety of probiotics and synbiotics in children under 18 years of age. Beneficial Microbes, 6: 615-630.
Verdenelli M. C., Ricciutelli M., Gigli F., Cenci G., Trotta, F., Caldini G. and Orpianesi, C., (2010). Investigation of the antigenotoxic properties of the probiotic Lactobacillus rhamnosus IMC 501® by gas chromatography-mass spectrometry. Italian Jornal of Food Science, 22: 473-478.
Wang H. K., Morris-Natschke S. L. and Lee K. H., (1997). Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents. Medicinal Research Reviews, 17: 367-425.
Waring M. J., (1965). The effects of antimicrobial agents on ribonucleic acid polymerase. Molecular Pharmacology, 1: 1-13.
Watkins T., (1952). 585. Trypanocides of the phenanthridine series. Part I. The effect of changing the quaternary grouping in dimidium bromide. Journal of the Chemical Society (Resumed), 3059-3064.
Whorwell P. J., Altringer L., Morel J., Bond Y., Charbonneau D., O'mahony L. and Quigley E. M., (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. The American Journal of Gastroenterology, 101: 1581-1590.
Woods D. B. and Vousden K. H., (2001). Regulation of p53 function. Experimental Cell Research, 264: 56-66.
Wu Y., Cai J., Cheng L., Yun K., Wang C. and Chen Y., (2006). Atomic force microscopic examination of chromosomes treated with trypsin or ethidium bromide. Chemical and Pharmaceutical Bulletin, 54: 501-505.
Yin H., Kim, M., Kim, J., Kong G., Kang K., Kim H. and Lee B., (2007). Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicology and applied pharmacology, 223: 225-233.
